October 4, 2010 | In: Healthcare
Sanofi, Genzyme, and Hostile Takeovers
Sanofi is after Genzyme for a few months now, with no avail. Genzyme just won't sell. Sanofi today began a hostile takeover to buy Genzyme. The hostile takeover values the company at $18.5 billion, or $69 per share, the same price that Sanofi offered to...